作者: Fumiko Koike , Jun-ichi Satoh , Sachiko Miyake , Toshiyuki Yamamoto , Mitsuru Kawai
DOI: 10.1016/S0165-5728(03)00155-3
关键词:
摘要: The molecular mechanisms for the interferon beta (IFNbeta) treatment of multiple sclerosis (MS) remain to be characterized. Using cDNA microarray technology, we have compared gene expression profile T and non-T cells derived from relapsing-remitting MS before after with IFNbeta-1b. IFNbeta significantly altered 21 genes out 1263 at 3 6 months treatment. These included nine IFN-responsive promoter elements. Whereas there was no change in Th1 or Th2 marker genes, some changes were unexpected but coincided beneficial effect MS.